Oviva Therapeutics

We're thrilled to have this topic, and our work at Oviva Therapeutics, covered in this brilliant piece by Alisha Haridasani Gupta and Dana G Smith for The New York Times. Jennifer Garrison said it best -- “If you don’t think about ovarian function during aging, then you’re kind of missing the boat.” This growing awareness and attention to this space is allowing us to finally better understand how female bodies work and, importantly, to ask essential questions that have never been asked (or answered), including why (and how) the ovaries are the only organ in humans that just stop functioning partway through our lives. What impacts to health - and quality of life - would be possible if we could align the aging of the ovaries with the rest of our bodies? Our mission at Oviva is to deliver solutions so that women might be afforded the opportunity to find out. #womenshealth #innovation #longevity #health #lifespan #biotech Daisy Robinton, PhD https://lnkd.in/gmVXDYGM

Very excited to take the stage at the SHEmedia Co-Lab at SXSW this year alongside some of my favorite people (Jennifer Garrison I'm looking at you!) Very ready to discuss innovations in women's health, including the work we're doing at Oviva Therapeutics to give women more agency over their health through first-in-class therapeutics that improve/preserve ovarian function (and female healthspan..!) See you there..! #sxsw2024 #innovation #womenshealth #femaleceo #futureofmedicine #menopause #fertility #biotech #longevity #healthspan

I'm looking forward to joining Jennifer Garrison and some of my favorite scientists and thinkers in the reproductive aging space this year at the 3rd Reproductive Aging conference in Cancun! I'll be speaking about our ongoing work and progress at Oviva Therapeutics, and can't wait to hear the other exciting talks on the agenda! #womenshealth #reproductivehealth #science #data #research #innovation #collaboration

Catch our CEO Daisy Robinton, PhD speaking at the 3rd Reproductive Aging Conference this May about the latest work here at Oviva Therapeutics. This seminal event has been a cornerstone of collaboration and idea-sharing in this emerging space, with thought-provoking talks and exciting science from the best and brightest scientists in the space. We hope to see you there! Jennifer Garrison Francesca Duncan David Pepin Mary Zelinski #science #research #collaboration #womenshealth #longevity #aging #reproductivehealth #data #collaboration #insight https://lnkd.in/gJCrUTZ9

"Oviva hopes to pull off a feat that seems almost unimaginable: giving women a drug that will allow them to choose when—and whether—they go through menopause. At a time when politicians are eroding women’s hard-won reproductive choices, Oviva’s founders want to give them even more control. 'I see it very much akin to how the contraceptive pill really changed the game for women in the ’70s,' Daisy Robinton, PhD says." We are thrilled and humbled to be featured in this insightful story from Bloomberg via Kristen V. Brown detailing the latest innovations in women's health and the effort to forestall or eradicate menopause -- and in doing so possibly preserving fertility and female healthspan. Our co-founders David Pepin and Daisy Robinton, PhD were interviewed for the piece, along with several other luminaries from the field. Check it out below! https://lnkd.in/gec9jXuD #womenshealth #innovation #longevity #healthspan #futureofhealth #health #medicine #menopause #fertility Oviva Therapeutics Jennifer Garrison Rachel Rimsky Rubin Lorna Fiedler, PhD Cambrian Bio James Peyer, PhD

Catch our CEO Daisy Robinton, PhD on the women's health follow-up to "Forever Young?" featured on BBC Click, BBC One,  BBC News and BBC iPlayer this coming weekend. Developed and presented by Lara Lewington this piece explores the question of whether we can - and whether we should - delay menopause. We're thrilled for our work to be shared on this platform to highlight the incredible innovation happening in this space and the possibilities that this work enable for women everywhere. Thank you, Lara & team! #womenshealth #longevity #menopause #innovation #biotech #futureofhealth

Catch the latest Op-Ed from our CEO and Co-Founder Daisy Robinton, PhD for Flow Health: "...while the age of menopausehas remained unchanged, our life expectancy has stretched into the eighth decade of life. For women, and individuals with ovaries, menopause is now the midpoint in our lives: 40 percent of our lifespan is lived in a post-menopausal body. " #innovation #womenshealth #aging #menopause #longevity #futureofhealthcare

Join our co-founder / CEO Daisy Robinton, PhD in conversation with Jennifer Garrison tomorrow evening for a conversation about female reproductive aging as part of The Longevity Dialogues series! Details and registration below: https://lu.ma/p5lxq543 #womenshealth #longevity #aging #innovation

Join our co-founder and CEO Daisy Robinton, PhD in conversation with Jennifer Garrison for the next 'Longevity Dialogues' event in SF - we're excited to hear what comes from this engaging conversation centered on reproductive aging and innovation in this field. Check it out below! #aging #longevity #womenshealth #innovation #health #wellness #healthspan #futureofhealth

We are consistently grateful for our co-founder David Pepin - not only for the thoughtfulness and rigor with which he conducts his research, but the creativity and innovation that he brings to his work and the broader field of reproductive medicine and women's health. We couldn't be more proud as he is honored today at the American Society for Reproductive Medicine - ASRM in recognition of the impact of his work. Congratulations, David, well-deserved!! #womenshealth #innovation #medicine #health #contraception #asrm2023